Loss of Expression and Aberrant Methylation of the CDH1 (E-cadherin) Gene in Breast Cancer Patients from Kashmir |
Asiaf, Asia
(Department of Biochemistry, Faculty of Biological Science, University of Kashmir)
Ahmad, Shiekh Tanveer (Clarke H. Smith Brain Tumour Centre, University of Calgary) Aziz, Sheikh Aejaz (Department of Medical Oncology, Sher-I-Kashmir Institute of Medical Sciences) Malik, Ajaz Ahmad (Department Of General Surgery, Sher-I-Kashmir Institute of Medical Sciences) Rasool, Zubaida (Department Of Pathology, Sher-I-Kashmir Institute of Medical Sciences) Masood, Akbar (Department of Biochemistry, Faculty of Biological Science, University of Kashmir) Zargar, Mohammad Afzal (Department of Biochemistry, Faculty of Biological Science, University of Kashmir) |
1 | Acs G, Lawton TJ, Rebbeck TR, et al (2001). Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Path, 115, 85-98. DOI ScienceOn |
2 | Andrews JL, Kim AC, Hens JR (2012). The role and function of cadherins in the mammary gland. Breast Cancer Res, 14, 203-13. |
3 | Baylin SB, Herman JG (2000). DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet, 16, 168-74. DOI ScienceOn |
4 | Berx G, Cleton-Jansen AM, Nollet F, et al (1995). E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J, 14, 6107. |
5 | Brock MV, Gou M, Akiyama Y, et al (2003). Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin cancer res, 9, 2912-9. |
6 | Caldeira JRF, Prando EC, Quevedo FC, et al (2006). CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC cancer, 6, 48. DOI |
7 | Cavallaro U, Christofori G (2004). Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer, 4, 118-32. DOI ScienceOn |
8 | Debies MT, Welch DR (2001). Genetic basis of human breast cancer metastasis. J Mammary Gland Biol Neoplasia, 6, 441-51. DOI |
9 | Elledge RM, Green S, Pugh R, et al (2000). Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immunohistochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study. Int J Cancer, 89, 111-7. DOI |
10 | Fisher B, Redmond C, Brown A, et al (1983). Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J Clin Oncol, 1, 227-41. |
11 | Graff JR, Gabrielson E, Fujii H, et al (2000). Methylation patterns of the E-cadherin 5'- CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem, 275, 2727-32. DOI ScienceOn |
12 | Graff JR, Herman JG, Lapidus RG, et al (1995). E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res, 55, 5195-9. |
13 | Hirohashi S (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Path, 153, 333-9. DOI ScienceOn |
14 | Hajra KM, Ji X, Fearon ER (1999). Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene, 18. |
15 | Harvey JM, Clark GM, Osborne CK, et al (1999). Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol, 17, 1474-. |
16 | Hennig G, Lowrick O, Birchmeier W, et al (1996). Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem, 271, 595-602. DOI |
17 | Hu X-C, Loo WTY, Chow LWC (2002). E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman. Life sci, 71, 1397-404. DOI ScienceOn |
18 | Issa JP, Ahuja N (2000). Aging, methylation and cancer. Histol Histopathol, 15, 835-42. |
19 | Kanai Y, Oda T, Tsuda H, et al (1994). Point mutation of the ecadherin gene in invasive lobular carcinoma of the breast. Cancer Sci, 85, 1035-9. DOI |
20 | Kowalski PJ, Rubin MA, Kleer CG (2003). E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res, 5, 217-22. DOI |
21 | Li S, Rong M, Iacopetta B (2006). DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett, 237, 272-80. DOI ScienceOn |
22 | Lo P-K, Sukumar S (2008). Epigenomics and breast cancer. Pharmacogenomics. |
23 | Overduin M, Harvey TS, Bagby S, et al (1995). Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science, 267, 386-9. DOI |
24 | Lombaerts M, Middeldorp JW, van der Weide E, et al (2004). Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors. Biochem Bioph Res Co, 319, 697-704. DOI |
25 | Nass SJ, Herman JG, Gabrielson E, et al (2000). Aberrant methylation of the estrogen receptor and E-cadherin 5 CpG islands increases with malignant progression in human breast cancer. Cancer Res, 60, 4346-8. |
26 | Oka H, Shiozaki H, Kobayashi K, et al (1992). Correlation between E-cadherin expression and metastasis in human breast cancer: preliminary report. Nihon Geka Gakkai zasshi, 93, 105. |
27 | Peinado H, Ballestar E, Esteller M, et al (2004). Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol, 24, 306-19. DOI ScienceOn |
28 | Prasad CP, Mirza S, Sharma G, et al (2008). Epigenetic alterations of CDH1 and APC genes: Relationship with activation of Wnt/beta- catenin pathway in invasive ductal carcinoma of breast. Life Sci, 83, 318-25. DOI |
29 | Raish M, Dhillon VS, Ahmad A, et al (2009). Promoter hypermethylation in tumor suppressing genes p16 and FHIT and their relationship with estrogen receptor and progesterone receptor status in breast cancer patients from Northern India. Transl Oncol, 2, 264. DOI |
30 | Ronneberg JA, Fleischer T, Solvang HK, et al Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Mol Oncol, 5, 61-76. |
31 | Sebova K, Zmetakova I, Bella V, et al (2011). RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer. Cancer Epidemiol Biomarkers Prev, 10, 13-26. |
32 | Rose C, Andersen K, Mouridsen H, et al (1985). Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. The Lancet, 325, 16-9. DOI |
33 | Sadot E, Simcha I, Shtutman M, et al (1998). Inhibition of -catenin-mediated transactivation by cadherin derivatives. Proc Natl Acad Sci USA, 95, 15339-44. DOI |
34 | Sarrio D, Perez-Mies B, Hardisson D, et al (2004). Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene, 23, 3272-83. DOI ScienceOn |
35 | Shargh SA, Sakizli M, Farajnia S, et al (2011). Evaluation of methylation pattern in promoter region of E-cadherin gene and its relation to tumor grade and stage in breast cancer. Afr J Biotechnol, 10, 1745-51. |
36 | Shinozaki M, Hoon DSB, Giuliano AE, et al (2005). Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res, 11, 2156-62. DOI ScienceOn |
37 | Syeed N, Husain SA, Abdullah S, et al (2010). Caveolin-1 promotes mammary tumorigenesis: mutational profile of the Kashmiri population. Asian Pac J Cancer Prev, 11, 689-96. |
38 | Szyf M, Pakneshan P, Rabbani SA (2004). DNA methylation and breast cancer. Bioche Pharmacol, 68, 1187-97. DOI ScienceOn |
39 | Tamura G, Yin J, Wang S, et al (2000). E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst, 92, 569-73. DOI ScienceOn |
40 | Tao MH, Shields PG, Nie J, et al (2009). DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Tr, 114, 559-68. DOI |
41 | Valavaara R, Tuominen J, Johansson R (1990). Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene. Cancer, 66, 2264-9. DOI |
42 | Vos CB, Cleton-Jansen AM, Berx G, et al (1997). E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer, 76, 1131. DOI ScienceOn |
43 | Wani SQ, Khan T, Wani SY, et al (2012). Clinicoepidemiological analysis of female breast cancer patients in Kashmir. J Can Res Ther, 8, 389. DOI |
44 | Xiong H-L, Liu X-Q, Sun A-H, et al (2013). Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer. Asian Pac J Cancer Prev, 14, 3139-42. 과학기술학회마을 DOI |
45 | Yang X, Yan L, Davidson NE (2001). DNA methylation in breast cancer. Endocr-Relat Cancer, 8, 115-27. DOI ScienceOn |
46 | Yoder BJ, Wilkinson EJ, Massoll NA (2007). Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast J, 13, 172-9. DOI ScienceOn |
47 | Yoshida R, Kimura N, Harada Y, et al (2001). The loss of E-cadherin, and -catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int J Oncol, 18, 513. |
48 | Yuan Y-L, Wang Y-M, Liu H, et al (2012). Aberrant expression of e-cadherin in lung tissues of patients with probable lung cancer. Asian Pac J Cancer Prev, 13, 5149-53. 과학기술학회마을 DOI |
49 | Zheng, Shi-Ying, Hou, et al (2012). Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer. Asian Pac J Cancer Prev, 13, 1557-61. 과학기술학회마을 DOI |
50 | Mir MR, Shabir N, Wani KA, et al (2012). Association between p16, hMLH1 and E-cadherin promoter hypermethylation and intake of local hot salted tea and sun-dried foods in Kashmiris with gastric tumors. Asian Pac J Cancer Prev, 13, 181-6. 과학기술학회마을 DOI ScienceOn |
51 | Sofi GN, Sofi JN, Nadeem R, et al (2012). Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev, 13, 5047-52. 과학기술학회마을 DOI ScienceOn |